We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
AstraZeneca PLC | NASDAQ:AZN | NASDAQ | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.75 | 0.99% | 76.55 | 55.00 | 77.24 | 76.49 | 75.43 | 76.47 | 9,026,349 | 05:00:07 |
By Dan Michaels
BRUSSELS--The European Union's health agency said it had found possible links between AstraZeneca PLC's Covid-19 vaccine and rare blood clots but said the shot's benefits continue to outweigh potential risks. The European Medicines Agency found no specific risk factors linking the vaccine to the clots.
Write to Dan Michaels at dan.michaels@wsj.com
(END) Dow Jones Newswires
April 07, 2021 10:30 ET (14:30 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year AstraZeneca Chart |
1 Month AstraZeneca Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions